Pelin Mutlu

1.1k total citations
37 papers, 802 citations indexed

About

Pelin Mutlu is a scholar working on Molecular Biology, Oncology and Biomaterials. According to data from OpenAlex, Pelin Mutlu has authored 37 papers receiving a total of 802 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 10 papers in Oncology and 9 papers in Biomaterials. Recurrent topics in Pelin Mutlu's work include Nanoparticle-Based Drug Delivery (9 papers), RNA Interference and Gene Delivery (5 papers) and Dendrimers and Hyperbranched Polymers (5 papers). Pelin Mutlu is often cited by papers focused on Nanoparticle-Based Drug Delivery (9 papers), RNA Interference and Gene Delivery (5 papers) and Dendrimers and Hyperbranched Polymers (5 papers). Pelin Mutlu collaborates with scholars based in Türkiye, United States and Cyprus. Pelin Mutlu's co-authors include Ufuk Gündüz, Serap Yalçın, Gözde Ünsoy, Rouhollah Khodadust, Ayşen Tezcaner, Önder Öngürü, Ali Uğur Ural, Yusuf Baran, Arzu Yakar and Güngör Gündüz and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Pharmaceutics and European Journal of Pharmacology.

In The Last Decade

Pelin Mutlu

34 papers receiving 788 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pelin Mutlu Türkiye 13 427 289 273 150 113 37 802
Linhua Zhang China 14 476 1.1× 280 1.0× 280 1.0× 94 0.6× 126 1.1× 28 814
Geoffrey Hollett United States 11 416 1.0× 247 0.9× 338 1.2× 83 0.6× 126 1.1× 13 805
Changying Shi United States 17 475 1.1× 376 1.3× 302 1.1× 189 1.3× 109 1.0× 37 1.0k
Iriny Ekladious United States 7 420 1.0× 265 0.9× 292 1.1× 113 0.8× 72 0.6× 12 799
Herdis Bludau Germany 6 402 0.9× 181 0.6× 199 0.7× 122 0.8× 75 0.7× 7 671
Weiguo Xu China 17 665 1.6× 321 1.1× 496 1.8× 111 0.7× 106 0.9× 25 993
Chengyuan Zhang China 14 456 1.1× 402 1.4× 366 1.3× 229 1.5× 123 1.1× 24 978
Meili Hou China 17 452 1.1× 229 0.8× 349 1.3× 100 0.7× 120 1.1× 27 738
Huaiyu Liu China 11 743 1.7× 408 1.4× 470 1.7× 151 1.0× 132 1.2× 13 1.1k
Prasanna Phutane India 4 438 1.0× 195 0.7× 242 0.9× 79 0.5× 80 0.7× 10 735

Countries citing papers authored by Pelin Mutlu

Since Specialization
Citations

This map shows the geographic impact of Pelin Mutlu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pelin Mutlu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pelin Mutlu more than expected).

Fields of papers citing papers by Pelin Mutlu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pelin Mutlu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pelin Mutlu. The network helps show where Pelin Mutlu may publish in the future.

Co-authorship network of co-authors of Pelin Mutlu

This figure shows the co-authorship network connecting the top 25 collaborators of Pelin Mutlu. A scholar is included among the top collaborators of Pelin Mutlu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pelin Mutlu. Pelin Mutlu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Mutlu, Pelin, et al.. (2024). Application of Inorganic Nanomaterials in Transdermal and Topical Medications: Influential Parameters, Opportunities and Challenges. Comments on Inorganic Chemistry. 45(2). 88–135. 2 indexed citations
4.
Mutlu, Pelin, et al.. (2023). Investigation of the Therapeutic Effects of Palbociclib Conjugated Magnetic Nanoparticles on Different Types of Breast Cancer Cell Lines. Cellular and Molecular Bioengineering. 16(2). 143–157. 8 indexed citations
5.
Mutlu, Pelin, et al.. (2022). Development of a microfluidic platform to maintain viability of micro-dissected tumor slices in culture. Biomicrofluidics. 16(3). 34103–34103. 2 indexed citations
6.
Mutlu, Pelin, et al.. (2022). NEK6 gene silencing using siRNA for overcome multidrug resistance in chronic myeloid leukemia cells. DergiPark (Istanbul University). 3(1). 1–6. 1 indexed citations
7.
Bayramlı, Erdal, Petek Korkusuz, Hakan Eroğlu, et al.. (2022). Vancomycin Containing PDLLA and PLGA/β-TCP Inhibit Biofilm Formation but Do Not Stimulate Osteogenic Transformation of Human Mesenchymal Stem Cells. Frontiers in Surgery. 9. 885241–885241. 4 indexed citations
8.
Mutlu, Pelin, et al.. (2020). Characterization of Gemcitabine Loaded Polyhydroxybutyrate Coated Magnetic Nanoparticles for Targeted Drug Delivery. Anti-Cancer Agents in Medicinal Chemistry. 20(10). 1233–1240. 16 indexed citations
10.
Mutlu, Pelin, et al.. (2016). Half generations magnetic PAMAM dendrimers as an effective system for targeted gemcitabine delivery. International Journal of Pharmaceutics. 515(1-2). 104–113. 30 indexed citations
11.
Ünsoy, Gözde, et al.. (2016). Loading of Gemcitabine on chitosan magnetic nanoparticles increases the anti-cancer efficacy of the drug. European Journal of Pharmacology. 784. 121–128. 78 indexed citations
12.
Yalçın, Serap, et al.. (2015). The -137G/C Polymorphism in Interleukin-18 Gene Promoter Contributes to Chronic Lymphocytic and Chronic Myelogenous Leukemia Risk in Turkish Patients. SHILAP Revista de lepidopterología. 32(4). 311–316. 7 indexed citations
13.
Mutlu, Pelin, Yağmur Kiraz, Ufuk Gündüz, & Yusuf Baran. (2015). An update on molecular biology and drug resistance mechanisms of multiple myeloma. Critical Reviews in Oncology/Hematology. 96(3). 413–424. 11 indexed citations
14.
Gündüz, Ufuk, Pelin Mutlu, Serap Yalçın, et al.. (2014). Idarubicin-loaded folic acid conjugated magnetic nanoparticles as a targetable drug delivery system for breast cancer. Biomedicine & Pharmacotherapy. 68(6). 729–736. 57 indexed citations
15.
Mutlu, Pelin, Serap Yalçın, Gözde Ünsoy, et al.. (2014). Association between XRCC3 Thr241Met polymorphism and laryngeal cancer susceptibility in Turkish population. European Archives of Oto-Rhino-Laryngology. 272(12). 3779–3784. 5 indexed citations
16.
Mutlu, Pelin, et al.. (2014). Identification of XRCC1 Arg399Gln and XRCC3 Thr241Met Polymorphisms in a Turkish Population and Their Association with the Risk of Chronic Lymphocytic Leukemia. Indian Journal of Hematology and Blood Transfusion. 31(3). 332–338. 6 indexed citations
17.
Ünsoy, Gözde, Serap Yalçın, Rouhollah Khodadust, et al.. (2014). Chitosan magnetic nanoparticles for pH responsive Bortezomib release in cancer therapy. Biomedicine & Pharmacotherapy. 68(5). 641–648. 52 indexed citations
18.
Mutlu, Pelin, Ali Uğur Ural, & Ufuk Gündüz. (2012). Differential gene expression analysis related to extracellular matrix components in drug-resistant RPMI-8226 cell line. Biomedicine & Pharmacotherapy. 66(3). 228–231. 12 indexed citations
19.
Mutlu, Pelin, Ali Uğur Ural, & Ufuk Gündüz. (2012). Differential oncogene-related gene expressions in myeloma cells resistant to prednisone and vincristine. Biomedicine & Pharmacotherapy. 66(7). 506–511. 5 indexed citations
20.
Abaan, Ogan D., Pelin Mutlu, Yusuf Baran, Can Atalay, & Ufuk Gündüz. (2009). Multidrug Resistance Mediated by MRP1 Gene Overexpression in Breast Cancer Patients. Cancer Investigation. 27(2). 201–205. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026